Tag: neonatal respiratory distress syndrome treatment market forecast

Uncover key drivers, emerging technologies, and competitive movements shaping the neonatal respiratory distress syndrome treatment market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Neonatal Respiratory Distress Syndrome Treatment Market in 2030?

The neonatal respiratory distress syndrome treatment market size has experienced significant growth in recent years. It is projected to expand from $1.03 billion in 2025 to $1.11 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.0%. This historical expansion can be attributed to factors such as high premature birth rates, the reliance on conventional oxygen therapy, limited access to neonatal intensive care units, the early adoption of natural surfactants, and increasing infant respiratory morbidity.

The neonatal respiratory distress syndrome treatment market is projected for significant expansion over the coming years. It is anticipated to reach $1.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period is primarily driven by the advancement of synthetic surfactants, the broadening use of non-invasive ventilation technologies, increased investment in neonatal care equipment, heightened global understanding of neonatal complications, and the modernization of hospital respiratory support systems. Key trends expected during this period involve the increasing adoption of surfactant replacement therapies, a rise in the utilization of CPAP and non-invasive ventilation, improvements in neonatal intensive care infrastructure, a greater emphasis on premature birth management, and the ongoing development of synthetic and bioengineered surfactants.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Drivers Are Influencing Production Trends In The Neonatal Respiratory Distress Syndrome Treatment Market?

The growing occurrence of premature births is anticipated to drive the expansion of the neonatal respiratory distress syndrome treatment market in the future. Premature births are defined as the delivery of babies prior to 37 weeks of gestation, leading to immature organ systems that necessitate specific medical assistance. A significant contributor to the increasing rate of premature births is the growing prevalence of maternal health issues, which can interfere with typical fetal development and induce early labor due to physiological stress on both the mother and the unborn child. Treatment for neonatal respiratory distress syndrome enhances survival rates and stabilizes premature infants, whose underdeveloped lungs make them highly susceptible to respiratory failure. As an illustration, Statistique Canada, a Canada-based governmental organization, reported in September 2024 that the percentage of births occurring before 37 weeks of gestation saw a slight increase from 8.2% in 2022 to 8.3% in 2023, reflecting a modest rise in preterm births. Consequently, the escalating incidence of premature births is fueling the expansion of the neonatal respiratory distress syndrome treatment market.

Which Segments Are Gaining Traction In The Neonatal Respiratory Distress Syndrome Treatment Market?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

What Trends Are Expected To Impact The Competitive Landscape Of The Neonatal Respiratory Distress Syndrome Treatment Market?

Leading companies in the neonatal respiratory distress syndrome treatment market are focusing on developing advanced solutions, such as next-generation, portable nitric-oxide delivery systems. These systems aim to improve oxygenation, minimize treatment complications, and expand access beyond traditional NICU settings. Portable nitric-oxide systems are medical devices that generate and deliver inhaled nitric oxide on demand, improving oxygenation and alleviating pulmonary hypertension in neonates with hypoxic respiratory failure, while also enabling safe use during patient transport. For instance, in June 2025, Beyond Air Inc., a US-based medical device company, submitted a PMA supplement to the U.S. Food and Drug Administration for LungFit PH 2, which is a lighter and transport-ready nitric oxide generator leveraging the company’s patented Ionizer technology. Designed for enhanced portability and convenience, this device maintains continuous nitric oxide delivery while minimizing nitrogen dioxide production, ensuring safer therapy even during neonatal transport. Concurrently, phase-4 registry data for INOmax, a well-established iNO therapy by Mallinckrodt, demonstrate continued real-world benefits in neonates with pulmonary hypertension, thereby reinforcing the clinical importance of inhaled nitric oxide in managing hypoxic respiratory failure in newborns.

Who Are The Primary Competitors In The Global Neonatal Respiratory Distress Syndrome Treatment Market?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Medtronic Plc, GE Healthcare, Koninklijke Philips NV, Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Windtree Therapeutics Inc., Discovery Laboratories Inc., ResMed Inc., Abbott Laboratories, Aerogen Pharma Corp., ONY Biotech, Yuhan Corporation, Atom Medical Corporation, Mindray Bio-Medical Electronics, Getinge AB, Nihon Kohden Corporation, Siare Engineering Spa

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

Which Regions Are Poised For Strategic Growth In The Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Neonatal Respiratory Distress Syndrome Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2026, By The Business Research Company

Lower Respiratory Tract Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/lower-respiratory-tract-therapeutics-global-market-report

Neonatal Infant Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Acute Respiratory Distress Syndrome Ards Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Neonatal Respiratory Distress Syndrome Treatment Market Be Worth By 2029?

In recent years, the market size for neonatal respiratory distress syndrome treatment has seen robust growth. It is expected to expand from a valuation of $0.96 billion in 2024 to $1.03 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.0%. The historical period growth is due to factors such as increased fluid accumulation and permeability within the alveoli, amplification in alveolar-capillary permeability, a rise in the use of mechanical ventilation, advancing consciousness among health care providers and parents regarding the significance of neonatal care, and the escalation in healthcare investments.

The market for neonatal respiratory distress syndrome treatment is projected to experience significant expansion in the coming years. The market value is set to reach $1.39 billion by 2029, with a compound annual growth rate (CAGR) of 7.9%. The expected growth during the forecast period is due to factors such as growing inclination towards accessories and consumables, increased NICU admissions, a surge in demand for personalized medicine, rise in premature births, and heightened research and development activities. Key trends forecasted in this timeframe include automation in neonatal intensive care units (NICUs), the application of artificial intelligence (AI), advancements in neonatal care technology, innovations in surfactant therapy, and the introduction of advanced ventilator technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

Which Key Factors Are Fueling Growth In The Neonatal Respiratory Distress Syndrome Treatment Market?

The neonatal respiratory distress syndrome treatment market is anticipated to grow owing to an increase in premature birth occurrences. Premature or preterm babies are those born before the 37th week of pregnancy, and those born before the 32nd week face the most serious health complications, as an average pregnancy lasts approximately 40 weeks. An upward trend in premature births is seen due to reasons like later maternal age, multiple pregnancies, varied health conditions, lifestyle decisions, utilization of fertility treatments, infections, and environmental factors. Neonatal respiratory distress syndrome (NRDS) treatment is typically necessary for preterm infants as their lungs are underdeveloped and there is inadequate surfactant production. This treatment aids in enhancing lung function, stabilizing breathing, and minimizing the likelihood of respiratory failure in premature infants. For example, Tommy’s, a UK-based charity, reported that the rate of premature live births in England and Wales climbed to 7.9% in 2022 from 7.5% in 2021, marking the second year in a row of an increase in premature births. Over 53,000 babies were prematurely born in 2022. Therefore, the uptick in premature births prevalence is fueling the growth of the neonatal respiratory distress syndrome treatment market.

Which Segmentation Factors Are Critical In The Neonatal Respiratory Distress Syndrome Treatment Market Analysis?

The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –

1) By Therapy: Oxygen Therapy; Surfactant Therapy

2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration

3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy

How Are Global Trends Impacting The Development Of The Neonatal Respiratory Distress Syndrome Treatment Market?

Key players in the neonatal respiratory distress syndrome treatment market are focusing on the innovation of high-tech solutions such as nitric oxide generators to boost oxygen levels, reduce respiratory problems, and provide non-invasive treatment for newborns with hypoxic respiratory failure. Nitric oxide generators are medicinal equipment that produce and supply nitric oxide gas, frequently used for addressing respiratory conditions by enhancing oxygenation and reducing pulmonary hypertension, particularly among neonates and severely sick patients. For example, in June 2022, Beyond Air Inc., a U.S. medical device and biopharmaceutical firm, earned FDA approval for LungFit PH. This ground-breaking nitric oxide generator is tailored to assist term and near-term newborns suffering from hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device leverages Beyond Air’s proprietary Ionizer technology to produce nitric oxide from surrounding air on demand, ensuring a continuous supply without worrying about dosage or flow, and it uses a low-power compressor to ionize nitrogen and oxygen, thereby reducing the production of nitrogen dioxide (NO2) which is then efficiently eliminated by a smart filter.

Which Players Are Shaping The Competitive Landscape Of The Neonatal Respiratory Distress Syndrome Treatment Market?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2025, By The Business Research Company

Fetal And Neonatal Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fetal-and-neonatal-monitoring-devices-global-market-report

Neonatal Infant Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Pediatric And Neonatal Testing Kit Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Neonatal Respiratory Distress Syndrome Treatment Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for neonatal respiratory distress syndrome treatments has experienced significant expansion in recent years. Its size is projected to expand from $0.96 billion in 2024 to $1.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.0%. This historical growth can be linked to several factors, including heightened permeability and fluid build-up within the alveoli, increased alveolar-capillary permeability, a rise in the deployment of mechanical ventilation, a greater understanding among healthcare professionals and parents regarding the significance of neonatal care, and increased financial commitments in healthcare.

The neonatal respiratory distress syndrome treatment market size is projected to experience robust expansion in the coming years. It is forecast to reach $1.39 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.9%. The anticipated growth during this period can be attributed to factors such as an increasing preference for accessories and consumables, a rise in NICU admissions, growing demand for personalized medicine, an increase in premature births, and heightened research and development activities. Significant trends expected during the forecast period include automation in neonatal intensive care units (NICUs), the integration of artificial intelligence (AI), continuous technological advancement in neonatal care, innovations in surfactant therapy, and the adoption of advanced ventilator technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Neonatal Respiratory Distress Syndrome Treatment Industry?

The increasing occurrence of premature births is anticipated to drive the expansion of the neonatal respiratory distress syndrome treatment market in the future. Premature birth, also known as preterm birth, occurs when a baby arrives prior to 37 weeks of gestation, with infants born before 32 weeks encountering the highest health risks, given that a standard pregnancy typically spans around 40 weeks. The incidence of premature births is on the rise, attributed to various factors including advanced maternal age, pregnancies involving multiple fetuses, existing health issues, personal lifestyle decisions, the application of fertility interventions, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) frequently affects premature babies because of their immature lungs and inadequate surfactant production. This treatment aids in enhancing lung functionality, stabilizing respiration, and lowering the likelihood of respiratory failure among premature infants. As an illustration, data from Tommy’s, a UK-based charity organization, indicated that in December 2022, the proportion of premature live births in England and Wales reached 7.9% in 2022, an increase from 7.5% in 2021. This represented the second consecutive year of an increase in premature births. In 2022, more than 53,000 babies were born prematurely. Consequently, the growing occurrence of premature births is propelling the neonatal respiratory distress syndrome treatment market.

What Are The Leading Segments Analyzed In The Neonatal Respiratory Distress Syndrome Treatment Market?

The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –

1) By Therapy: Oxygen Therapy; Surfactant Therapy

2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration

3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy

Which Market Trends Are Creating New Opportunities In The Neonatal Respiratory Distress Syndrome Treatment Industry?

Leading firms within the neonatal respiratory distress syndrome treatment market are focusing their efforts on creating sophisticated technologies, specifically nitric oxide generators, with the aim of improving oxygenation, reducing breathing complications, and providing non-invasive care for newborns experiencing hypoxic respiratory failure. This medical apparatus, a nitric oxide generator, produces and delivers nitric oxide gas, frequently employed to manage respiratory problems through enhanced oxygenation and the reduction of pulmonary hypertension, especially in infants and severely ill individuals. As an illustration, in June 2022, Beyond Air Inc., a medical device and biopharmaceutical company based in the US, secured FDA approval for its product, LungFit PH. This novel nitric oxide generator is specifically engineered to address hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN), in both term and near-term neonates. Leveraging Beyond Air’s proprietary Ionizer technology, the unit produces nitric oxide as needed from the surrounding air, ensuring an uninterrupted supply free from dose or flow limitations. It also employs a low-power compressor to ionize nitrogen and oxygen, thereby reducing the formation of nitrogen dioxide (NO2), which is subsequently removed safely by a smart filter.

Which Major Firms Are Strengthening Their Position In The Neonatal Respiratory Distress Syndrome Treatment Industry?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

How Is Neonatal Respiratory Distress Syndrome Treatment Market Demand Varying Across Different Regions?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Neonatal Respiratory Distress Syndrome Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Browse Through More Reports Similar to the Global Neonatal Respiratory Distress Syndrome Treatment Market 2025, By The Business Research Company

Fetal And Neonatal Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fetal-and-neonatal-monitoring-devices-global-market-report

Neonatal Infant Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Pediatric And Neonatal Testing Kit Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Neonatal Respiratory Distress Syndrome Treatment Market Expected to Grow Between 2025 And 2029?

The market size of neonatal respiratory distress syndrome treatment has witnessed significant growth in the past few years. The growth is projected to increase from $0.96 billion in 2024 to $1.03 billion in 2025, registering a compound annual growth rate (CAGR) of 7.0%. This growth during the historic period can be attributed to several factors such as the enhanced permeability and fluid accumulation within the alveoli, amplified alveolar-capillary permeability, surging use of mechanical ventilation, heightened awareness amid healthcare providers and parents regarding the crucialness of neonatal care, and escalated healthcare investments.

In the coming years, the market for neonatal respiratory distress syndrome treatment is forecasted to experience significant expansion. The market is predicted to reach $1.39 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is due to factors like an elevated inclination towards accessories and consumables, a surge in NICU admissions, the rise in personalized medicine demand, an increase in premature birth phenomena, and augmented research and development activities. The upcoming trends for the forecast period involve the incorporation of automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI) into systems, advances in neonatal care technology, innovative surfactant therapy, and enhanced ventilator technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

Which Factors and External Forces Are Driving Demand in the Neonatal Respiratory Distress Syndrome Treatment Market?

The neonatal respiratory distress syndrome treatment market’s growth is anticipated to be fuelled by the escalating prevalence of premature births. Premature birth or preterm birth occurs when a baby is delivered before the 37th week of gestation, with those births occurring before the 32nd week posing the gravest health hazards, considering a typical pregnancy endures about 40 weeks. The surge in premature births can be attributed to reasons like advanced maternal age, multifetal pregnancies, certain health ailments, lifestyle preferences, fertility treatment usage, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) treatment is often necessitated for preterm babies due to their underdeveloped lungs and inadequate surfactant production. This intervention increases lung functionality, normalizes respiration, and diminishes the likelihood of respiratory failure in preterm infants. For instance, Tommy’s, a charity organization based in the UK, stated in December 2022 that the rate of premature live births in England and Wales escalated to 7.9% in 2022 from 7.5% in 2021, marking the second consecutive year of an increase in premature births. Over 53,000 infants were delivered prematurely in 2022. Consequently, the burgeoning occurrence of premature births is propelling the neonatal respiratory distress syndrome treatment market.

Which Segments in the Neonatal Respiratory Distress Syndrome Treatment Offer the Most Growth?

The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –

1) By Therapy: Oxygen Therapy; Surfactant Therapy

2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration

3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Neonatal Respiratory Distress Syndrome Treatment Market?# Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theNeonatal Respiratory Distress Syndrome Treatment Market’s Growth?

Key industry players in the treatment market for neonatal respiratory distress syndrome are focusing on creating cutting-edge technologies such as nitric oxide generators. These innovations aim to improve oxygenation, reduce respiratory issues and provide non-invasive treatment options for newborns suffering from hypoxic respiratory failure. Medical devices like nitric oxide generators enable the production and administration of nitric oxide gas, typically used to enhance oxygenation and lessen pulmonary hypertension especially in neonates and severely sick patients. For example, Beyond Air Inc., a US-based firm specializing in medical devices and biopharmaceuticals, was granted FDA approval for LungFit PH in June 2022. This state-of-the-art nitric oxide generator is developed to assist term and near-term neonates struggling with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). Leveraging on their proprietary Ionizer technology, the device produces nitric oxide from surrounding air anytime it’s needed, ensuring an unlimited supply without worrying about the dosage or flow. The device uses a low-power compressor to ionize nitrogen and oxygen, subsequently lowering the production of nitrogen dioxide (NO2), which is eventually safely eliminated using a smart filter.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

What Are the Key Elements That Define the Neonatal Respiratory Distress Syndrome Treatment Market?

Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Neonatal Respiratory Distress Syndrome Treatment Market Growth in 2025?

In the past few years, the neonatal respiratory distress syndrome treatment market has seen substantial growth. It is anticipated to rise from $0.96 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the historical period include enhanced permeability and fluid build-up within the alveoli, an increase in alveolar-capillary permeability, increased use of mechanical ventilation, heightened awareness of neonatal care importance among healthcare providers and parents, as well as greater investments in healthcare.

What Is the Forecast for the Neonatal Respiratory Distress Syndrome Treatment Market Size Through 2029?

Anticipations are set for a robust expansion in the neonatal respiratory distress syndrome treatment market in the upcoming years. The predicted growth places it at $1.41 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. Increased attraction towards accessories and consumables, an upswing in NICU admissions, growing demand for personalised medicine, rising instances of premature birth, and an upturn in research and development initiatives are all contributing factors for the growth projected in this period. Key trends foresee an increase in automation within neonatal intensive care units (NICUs), artificial intelligence (AI) integration, progresses in neonatal care technology, surfactant therapy advances, and evolution in ventilator technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What are the Key Market Players in Neonatal Respiratory Distress Syndrome Treatment Market and How They’re Evolving?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

What Are the Primary Growth Drivers in the Neonatal Respiratory Distress Syndrome Treatment Market?

The increase in premature births is expected to stimulate growth in the neonatal respiratory distress syndrome treatment market. A premature birth, or preterm birth, occurs when a baby is born before the 37th week of pregnancy. Babies born prior to the 32nd week are at the highest risk due to their underdeveloped lungs and insufficient production of surfactant. The incidence of premature births is on the rise due to factors including advanced maternal age, multiple pregnancies, existing health problems, lifestyle choices, use of fertility treatments, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) treatment is often necessary for these premature babies, as it aids in improving lung function, stabilizing breaths, and minimizing the threat of respiratory failure. For example, Tommy’s, a charity organization based in the UK, reported in December 2022 that the percentage of live premature births in England and Wales rose from 7.5% in 2021 to 7.9% in 2022, marking the second successive year of growth in premature births. Over 53,000 babies were born prematurely in 2022 as a result. Therefore, the escalating incidence of premature births is fueling the growth of the neonatal respiratory distress syndrome treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

What Are the Leading Segments in the Global Neonatal Respiratory Distress Syndrome Treatment Industry?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

What Are the Key Market Trends in the Neonatal Respiratory Distress Syndrome Treatment Industry?

In the neonatal respiratory distress syndrome treatment market, leading corporations are focusing on developing cutting-edge technology, such as nitric oxide generators, to improve oxygenation, reduce respiratory problems, and provide non-invasive therapies for newborns with hypoxic respiratory failure. A nitric oxide generator, as a medical instrument, generates and delivers nitric oxide gas which is usually employed to address respiratory complications by increasing oxygenation and alleviating pulmonary hypertension, mainly in newborns and seriously ill individuals. For instance, Beyond Air Inc., a medical device and biopharmaceutical corporation based in the US, achieved FDA approval for LungFit PH in June 2022. This novel nitric oxide generator is manufactured to treat term and near-term newborns with hypoxic respiratory failure, encompassing persistent pulmonary hypertension of the newborn (PPHN). The device uses Beyond Air’s proprietary Ionizer technology to produce nitric oxide from surrounding air on demand, ensuring an unlimited supply without concerns about dosage or flow. It employs a low-energy compressor to ionize nitrogen and oxygen, thereby curbing nitrogen dioxide (NO2) production, which is then safely removed through a smart filter.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

What Is the Regional Outlook for the Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

This Report Delivers Insight On:

1. How big is the neonatal respiratory distress syndrome treatment market, and how is it changing globally?

2. Who are the major companies in the neonatal respiratory distress syndrome treatment market, and how are they performing?

3. What are the key opportunities and risks in the neonatal respiratory distress syndrome treatment market right now?

4. Which products or customer segments are growing the most in the neonatal respiratory distress syndrome treatment market?

5. What factors are helping or slowing down the growth of the neonatal respiratory distress syndrome treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What is the Projected CAGR for the Neonatal Respiratory Distress Syndrome Treatment Market Size from 2025 to 2034?

In recent years, the market size for neonatal respiratory distress syndrome treatment has seen robust growth. The money generated by this market is forecasted to rise from $0.96 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to the growth in the historic period include an increase in permeability and fluid buildup within the alveoli, heightened alveolar-capillary permeability, a surge in the use of mechanical ventilation, more awareness amongst healthcare professionals and parents on neonatal care’s significance, as well as an uptick in healthcare investments.

Growth in the neonatal respiratory distress syndrome treatment market is anticipated to be robust in the coming years, with estimations suggesting a value of $1.41 billion by 2029, representing a compound annual growth rate (CAGR) of 8.0%. This upward trajectory during the forecast period is largely due to factors such as the increasing inclination towards accessories and consumables, a surge in NICU admissions, a growing demand of personalized medicine, an increase in premature birth occurrences, and a rise in research and development initiatives. Some key trends expected during the forecast period include the automation of neonatal intensive care units (NICUs), the incorporation of artificial intelligence (AI), progresses in neonatal care technology, innovative surfactant therapies, and advanced ventilator technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What Are the Core Market Drivers Propelling Growth in the Neonatal Respiratory Distress Syndrome Treatment Industry?

The escalating rates of premature births is projected to boost the growth trajectory of the neonatal respiratory distress syndrome treatment market. A preterm birth, also known as premature birth, is when a baby arrives before the 37th week of pregnancy. Those born prior to the 32nd week face significant health threats – a typical pregnancy is approximately 40 weeks. Factors such as increasing maternal age, multiple pregnancies, health issues, lifestyle decisions, fertility treatment usage, infections, and environmental factors contribute to the upsurge in premature births. The need for Neonatal Respiratory Distress Syndrome (NRDS) treatment is frequent among premature newborns because their lungs are immature and there is inadequate surfactant production. This therapy aids in lung function improvement, breathing stabilization, and the reduction of premature infants’ risk of respiratory failure. For example, Tommy’s, a UK-based charity organization, reported in December 2022 that the percentage of live premature births in England and Wales spiked to 7.9% in 2022 from 7.5% in 2021, demonstrating a sequential rise in premature birth incidence. Over 53,000 babies were prematurely born in 2022, highlighting the reason behind the meandering trajectory of the neonatal respiratory distress syndrome treatment market.

How Is the Neonatal Respiratory Distress Syndrome Treatment Market Segmented?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

Which Regions Are Driving the Next Phase of the Neonatal Respiratory Distress Syndrome Treatment Market Growth?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive the Neonatal Respiratory Distress Syndrome Treatment Market’s Growth?

Leading firms in the neonatal respiratory distress syndrome treatment market are focusing on the advancement of technologies such as nitric oxide generators. These aim to improve oxygenation, reduce respiratory issues, and provide non-invasive treatment methods for neonates suffering from hypoxic respiratory failure. A nitric oxide generator is a medical apparatus that produces and dispenses nitric oxide gas, which is usually used to address respiratory problems by enhancing oxygen levels and reducing pulmonary hypertension chiefly in neonates and intensely sick patients. In a recent development, Beyond Air Inc., a US-based medical device and biopharmaceutical organization, secured FDA approval for LungFit PH in June 2022. This ground-breaking nitric oxide generator is intended to treat term and near-term neonates who have hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device uses Beyond Air’s proprietary Ionizer technology to create nitric oxide from ambient air on demand, supplying an unrestricted source without any worries over dosage or flow. The technology empowers a low-power compressor to ionize nitrogen and oxygen, thereby reducing nitrogen dioxide (NO2) production which is then securely removed via a smart filter.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

How Is the Neonatal Respiratory Distress Syndrome Treatment Market Defined and What Are Its Core Parameters?

Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model